Novonix (NVNXF) Equity Ratio (2020 - 2025)

Novonix has reported Equity Ratio for 6 years, with the latest figure at 0.57 in Q4 2025.

• For the quarter ending Q4 2025, Equity Ratio fell 6.1% year-over-year to 0.57; the trailing twelve-month figure through Dec 2025 stood at 0.57 (down 6.1% YoY), and the FY2025 full-year result was 0.57, down 6.1% from the prior year.
• Equity Ratio for Q4 2025 stood at 0.57, up from 0.51 in the prior quarter.
• The five-year high for Equity Ratio was 0.91 in Q2 2021, with the low at 0.49 in Q2 2023.
• Historically, Equity Ratio has averaged 0.68 across 5 years, with a median of 0.65 in 2023.
• Annual changes were most pronounced in 2021 — Equity Ratio rose 5.66% — and 2023, when it plunged 41.46%.
• Novonix's Equity Ratio stood at 0.91 in 2021, then dropped by 10.36% to 0.81 in 2022, then dropped by 14.28% to 0.7 in 2023, then decreased by 12.87% to 0.61 in 2024, then fell by 6.1% to 0.57 in 2025.
• The last three Equity Ratio figures came in at 0.57 (Q4 2025), 0.51 (Q2 2025), and 0.61 (Q4 2024), per Business Quant data.